Search - Université de Rennes Access content directly

Filter your results

10 Results
Author: personID (integer) : 759753
Image document

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag , Serge Koscielny , Jacques Bosq , Thibaut Leguay , Olivier Casasnovas et al.
The Lancet, 2016, 387 (10036), pp.2402 - 2411. ⟨10.1016/S0140-6736(15)01317-3⟩
Journal articles inserm-01419476v1

Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group

Thorsten Braun , Sophie Cereja , Sylvie Chevret , Emmanuel Raffoux , Marie Beaumont et al.
Cancer, 2015, 121 (14), pp.2393-2399. ⟨10.1002/cncr.29389⟩
Journal articles hal-01237097v1

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.

Raouf Ben Abdelali , Vahid Asnafi , Thibaut Leguay , Nicolas Boissel , Agnès Buzyn et al.
Blood, 2011, 118 (19), pp.5099-107. ⟨10.1182/blood-2011-02-334219⟩
Journal articles hal-00777203v1

A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study

Mathilde Hunault-Berger , Thibaut Leguay , Françoise Huguet , Stéphane Leprêtre , Eric Deconinck et al.
American Journal of Hematology, 2015, 90 (9), pp.811--818. ⟨10.1002/ajh.24093⟩
Journal articles hal-01237093v1

Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group

Lionel Adès , Xavier Thomas , Agnes Cuerci-Bres , Raffoux Emmanuel , Olivier Spertini et al.
Blood, 2015, 126 (23), pp.451
Journal articles hal-01300812v1
Image document

Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study

Stéphane Leprêtre , Aurore Touzart , Thomas Vermeulin , Jean-Michel Picquenot , Aline Schmidt-Tanguy et al.
Journal of Clinical Oncology, 2016, 34 (6), pp.572. ⟨10.1200/JCO.2015.61.5385⟩
Journal articles inserm-01411210v1
Image document

A Phase 2 Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

Hagop M. Kantarjian , Bruno Lioure , Ehab Atallah , Thibaut Leguay , Kevin Kelly et al.
Clinical Lymphoma, Myeloma & Leukemia, 2016, 16 (3), pp.139-145. ⟨10.1016/j.clml.2015.12.004⟩
Journal articles hal-01259441v1

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.

Mathilde Hunault-Berger , Thibaut Leguay , Xavier Thomas , Ollivier Legrand , Françoise Huguet et al.
Haematologica, 2011, 96 (2), pp.245-52. ⟨10.3324/haematol.2010.027862⟩
Journal articles hal-00821138v1
Image document

Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience

Marie-Anne Couturier , Françoise Huguet , Patrice Chevallier , Felipe Suarez , Xavier Thomas et al.
American Journal of Hematology, 2015, 90 (11), pp.986--991. ⟨10.1002/ajh.24130⟩
Journal articles hal-01231425v1

An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a group for research in adult acute lymphoblastic leukemia study

Jonathan Bond , Tony Marchand , Aurore Touzart , Agata Cieslak , Amélie Trinquand et al.
Haematologica, 2016, 101 (6), pp.732-740. ⟨10.3324/haematol.2015.141218⟩
Journal articles hal-01290420v1